Literature DB >> 27528705

A New Chromatin-Cytoskeleton Link in Cancer.

Amato J Giaccia1.   

Abstract

The set domain containing 2 (SETD2) histone methyltransferase, located at 3p2, specifically trimethylates lysine 36 of histone H3 (H3K36me3). H3K36me3 is an active mark involved in transcriptional elongation and RNA processing and a key regulator of DNA repair. In fact, SETD2 is the only methyltransferase that "writes" the H3K36me3 mark. Recent results from Park and colleagues have found a new role for SETD2 in the methylation of K40 of α-tubulin. Loss of SETD2 abolishes methylation of K40 of α-tubulin and results in a dysfunctional mitotic spindle and abnormalities in cytokinesis. Thus, SETD2 links chromatin and cytoskeleton homeostasis through its methyltransferase activity. These studies have important implications on the role of SETD2 mutations in promoting genomic instability and tumor progression. Mol Cancer Res; 14(12); 1173-5. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27528705      PMCID: PMC5136307          DOI: 10.1158/1541-7786.MCR-16-0250

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  18 in total

1.  Gene silencing associated with SWI/SNF complex loss during NSCLC development.

Authors:  Shujie Song; Vonn Walter; Mehmet Karaca; Ying Li; Christopher S Bartlett; Dominic J Smiraglia; Daniel Serber; Christopher D Sproul; Christoph Plass; Jiren Zhang; D Neil Hayes; Yanfang Zheng; Bernard E Weissman
Journal:  Mol Cancer Res       Date:  2014-01-20       Impact factor: 5.852

2.  SMARCB1/INI1 inactivation in renal medullary carcinoma.

Authors:  Julien Calderaro; Julien Moroch; Gaelle Pierron; Florence Pedeutour; Camille Grison; Pascale Maillé; Pascale Soyeux; Alexandre de la Taille; Jérome Couturier; Annick Vieillefond; Marie Christine Rousselet; Olivier Delattre; Yves Allory
Journal:  Histopathology       Date:  2012-06-11       Impact factor: 5.087

3.  Histone Methyltransferase hSETD1A Is a Novel Regulator of Metastasis in Breast Cancer.

Authors:  Tal Salz; Changwang Deng; Christine Pampo; Dietmar Siemann; Yi Qiu; Kevin Brown; Suming Huang
Journal:  Mol Cancer Res       Date:  2014-11-04       Impact factor: 5.852

4.  Active matrix metalloproteinase-7 is associated with invasion in buccal squamous cell carcinoma.

Authors:  Hui-Ching Chuang; Chih-Ying Su; Hsuang-Ying Huang; Chao-Cheng Huang; Chih-Yen Chien; Yung-Ying Du; Jiin-Haur Chuang
Journal:  Mod Pathol       Date:  2008-10-17       Impact factor: 7.842

Review 5.  Insights into the Genetic Basis of the Renal Cell Carcinomas from The Cancer Genome Atlas.

Authors:  Scott M Haake; Jamie D Weyandt; W Kimryn Rathmell
Journal:  Mol Cancer Res       Date:  2016-06-21       Impact factor: 5.852

6.  Loss of histone demethylase KDM6B enhances aggressiveness of pancreatic cancer through downregulation of C/EBPα.

Authors:  Keisuke Yamamoto; Keisuke Tateishi; Yotaro Kudo; Tomohiko Sato; Shinzo Yamamoto; Koji Miyabayashi; Keisuke Matsusaka; Yoshinari Asaoka; Hideaki Ijichi; Yoshihiro Hirata; Motoyuki Otsuka; Yousuke Nakai; Hiroyuki Isayama; Tsuneo Ikenoue; Mineo Kurokawa; Masashi Fukayama; Norihiro Kokudo; Masao Omata; Kazuhiko Koike
Journal:  Carcinogenesis       Date:  2014-06-19       Impact factor: 4.944

Review 7.  Targeting EZH2 in cancer.

Authors:  Kimberly H Kim; Charles W M Roberts
Journal:  Nat Med       Date:  2016-02       Impact factor: 53.440

8.  Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer.

Authors:  I Versteege; N Sévenet; J Lange; M F Rousseau-Merck; P Ambros; R Handgretinger; A Aurias; O Delattre
Journal:  Nature       Date:  1998-07-09       Impact factor: 49.962

9.  Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes.

Authors:  Gillian L Dalgliesh; Kyle Furge; Chris Greenman; Lina Chen; Graham Bignell; Adam Butler; Helen Davies; Sarah Edkins; Claire Hardy; Calli Latimer; Jon Teague; Jenny Andrews; Syd Barthorpe; Dave Beare; Gemma Buck; Peter J Campbell; Simon Forbes; Mingming Jia; David Jones; Henry Knott; Chai Yin Kok; King Wai Lau; Catherine Leroy; Meng-Lay Lin; David J McBride; Mark Maddison; Simon Maguire; Kirsten McLay; Andrew Menzies; Tatiana Mironenko; Lee Mulderrig; Laura Mudie; Sarah O'Meara; Erin Pleasance; Arjunan Rajasingham; Rebecca Shepherd; Raffaella Smith; Lucy Stebbings; Philip Stephens; Gurpreet Tang; Patrick S Tarpey; Kelly Turrell; Karl J Dykema; Sok Kean Khoo; David Petillo; Bill Wondergem; John Anema; Richard J Kahnoski; Bin Tean Teh; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2010-01-06       Impact factor: 49.962

10.  Targeted next-generation sequencing reveals high frequency of mutations in epigenetic regulators across treatment-naïve patient melanomas.

Authors:  Jonathan J Lee; Lynette M Sholl; Neal I Lindeman; Scott R Granter; Alvaro C Laga; Priyanka Shivdasani; Gary Chin; Jason J Luke; Patrick A Ott; F Stephen Hodi; Martin C Mihm; Jennifer Y Lin; Andrew E Werchniak; Harley A Haynes; Nancy Bailey; Robert Liu; George F Murphy; Christine G Lian
Journal:  Clin Epigenetics       Date:  2015-06-09       Impact factor: 6.551

View more
  1 in total

Review 1.  Clear cell renal cell carcinoma ontogeny and mechanisms of lethality.

Authors:  Eric Jonasch; Cheryl Lyn Walker; W Kimryn Rathmell
Journal:  Nat Rev Nephrol       Date:  2020-11-03       Impact factor: 28.314

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.